The Quantum Blue® rapid test combines the ease and speed of lateral flow technology (using a highly specific monoclonal antibody to calprotectin), with full quantification by means of a small, telephone sized reading device. The Quantum Blue® Reader analyzes the signal intensity from the test and control line to give a quantitative value and is standardized with the BÜHLMANN fCAL® ELISA.
Quantum Blue® fCAL high range: Health Canada License: 88674
Quantum Blue® fCAL extended: Health Canada License: 100161
Quantum Blue®Infliximab: Health Canada Licence: 98838
Quantum Blue®Adaliumumab: Health Canada Licence: 101776
US: (The Quantum Blue® tests are for Research Use Only. Not for use in diagnostic procedures in the US.)